ZyVersa Therapeutics, Inc. (ZVSA)
NASDAQ: ZVSA · Real-Time Price · USD
1.150
-0.070 (-5.74%)
Dec 27, 2024, 4:00 PM EST - Market closed
ZyVersa Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 27, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 3 | 5 | 14 | - | - |
| Market Cap Growth | -54.25% | -66.90% | - | - | - |
| Enterprise Value | 3 | 3 | 18 | - | - |
| Last Close Price | 1.15 | 9.00 | 549.50 | - | - |
| PB Ratio | 0.18 | 0.43 | 0.14 | - | - |
| Debt / Equity Ratio | - | 0.00 | 0.00 | -0.71 | -0.43 |
| Quick Ratio | 0.01 | 0.31 | 0.72 | 0.02 | 0.02 |
| Current Ratio | 0.03 | 0.33 | 0.78 | 0.06 | 0.04 |
| Return on Equity (ROE) | -159.59% | -177.53% | -32.53% | - | - |
| Return on Assets (ROA) | -23.02% | -12.82% | -14.45% | -531.56% | - |
| Return on Capital (ROIC) | -44.96% | -16.26% | -17.99% | - | - |
| Earnings Yield | -791.23% | -2083.02% | -99.05% | - | - |
| FCF Yield | -338.39% | -184.80% | -34.29% | - | - |
| Buyback Yield / Dilution | 97.10% | 99.57% | -849.06% | -3478.59% | - |
| Total Shareholder Return | 97.10% | 99.57% | -849.06% | -3478.59% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.